Skip to main content
. 2021 Mar 9;2021(3):CD013522. doi: 10.1002/14651858.CD013522.pub2

Sarna 2008.

Study characteristics
Methods Study design: longitudinal cohort
Country: USA
Data collection period: 1992/1993, 1996/1997, 2000/2001
Registry ID: N/A (cohort)
Participants Number of participants: N = 158,734; Number included in meta‐analysis: N = 11,809
Sample characteristics (at baseline):
Age (mean): range 29 – 71 years; Sex (% male): 0% (0/158,734)
Population category: general population; Specific population: female nurses
Nicotine dependence: not measured; Baseline cigarettes per day: 16.8 (SD 10.3); Motivation to quit: not selected by motivation to quit
Interventions Behavioural support for smoking cessation: no behavioural support
Pharmacological support for smoking cessation: no pharmacological support
Psychotherapeutic or psychoactive support for mental health or mood: did not receive mood management
Outcomes Definition of cessation used: self‐reported point prevalence (exact definition of abstinence not reported)
Cessation definition used for outcome(s) in this analysis: unclear point prevalence
Measure of biovalidation: not bioverified
Definition of people who continued smoking used: people who currently smoked (self‐reported)
Time point(s) at which follow‐up was conducted: baseline, 4 years and 8 years after baseline
Outcome category: Psychological Quality of Life (QoL), Social outcome
Outcome measure(s): Short Form Health Survey – 36 (SF‐36; mental health composite and social functioning subscale)
Funding source Supported by grants CA87979, CA50385, and K07 CA92696‐02 (Cooley) from the National Institutes of Health, and a grant from the Robert Wood Johnson Foundation #55769 (Sarna)
Author conflicts of interest None specified
Notes Outcome data source: Published data